Corporate Giving

Funding and support

Beyond developing new therapies for those in need, GBT is committed to collaborating with patients, advocacy groups, healthcare professionals (HCPs) and researchers. We do this through grants, charitable contributions, sponsorships and research opportunities.

GBT Community Fund

As a result of the COVID-19 pandemic, the sickle cell disease (SCD) community is in a time of crisis, as many patients and family members struggle to access critical services and require help to meet their basic needs, including food, water, protective gear, basic supplies, mental health, educational and other support services. The GBT Community Fund provided $150,000 in grants to support the acute needs of SCD patients and families during the COVID-19 pandemic.

Visit the COVID-19 Information and Resources page for more information about GBT’s response to the pandemic.

Community Engagement & Partnership

Community is our strength and inspiration. Since the beginning, we have collaborated closely with the sickle cell community to make a difference in patient care for those with SCD and other grievous blood-based disorders. We continue to work closely with patient advocacy groups, community-based organizations, SCD treatment centers and key government stakeholders to support innovative programs, education and awareness activities.

Medical Affairs

GBT collaborates with researchers, physicians, public health experts and others who share our passion for creating medicines for SCD. We sponsor research conducted by external scientists with the goal of advancing scientific knowledge and patient care within our clinical areas of interest. We also support continuing medical education and educational initiatives aimed at healthcare professionals.

How we’re committed to ACCELerating progress

We are particularly proud of our Access to Excellent Care for Sickle Cell Patients Program (ACCEL), which provides grant funding to support novel projects aimed at accelerating the development of innovative and sustainable programs with the goal of addressing the gaps and disproportionate disparities in care that people living with SCD face throughout their lives. Over time, these programs will have the potential to dramatically improve access to high-quality, comprehensive healthcare for people with SCD. To date, more than $200,000 in grants have been awarded. In 2020, the ACCEL program will fund up to five proposals from U.S.-based nonprofit organizations, providing a grant of up to $50,000 each.

Priority areas for proposed access-to-care programs may include, but are not limited to:

  • Expanding existing community outreach models using community health workers to facilitate patient access to care
  • Innovative training programs that focus on novel approaches to training health care professionals on the management of SCD and patients’ needs
  • Leveraging available capacity by partnering with non-SCD stakeholders
  • Improving transition from pediatric to adult care
  • Innovative Nurse Practitioner outreach care models